Published in Acta Psychiatr Scand on April 01, 1988
Cognitive and symptomatic predictors of functional disability in schizophrenia. Schizophr Res (2010) 1.35
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci (2010) 0.98
Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond. Eur Arch Psychiatry Clin Neurosci (2008) 0.80
Prognostic Value of Affective Symptoms in First-Admission Psychotic Patients. Int J Mol Sci (2016) 0.78
Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. I. Definitions, methods, psychopathological and social outcome. Eur Arch Psychiatry Neurol Sci (1989) 0.75
Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. III. Social consequences. Eur Arch Psychiatry Neurol Sci (1989) 0.75
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition. Eur Arch Psychiatry Clin Neurosci (2008) 0.75
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry (1988) 12.83
Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav (1999) 3.20
Traumatic events and post-traumatic stress disorder in the community: prevalence, risk factors and comorbidity. Acta Psychiatr Scand (2000) 2.98
Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry (1999) 2.97
Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study. Eur Arch Psychiatry Clin Neurosci (1992) 2.68
Prevalence of suicide ideation and suicide attempts in nine countries. Psychol Med (1999) 2.50
Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry (1996) 2.48
WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry (1994) 2.25
Sex differences in rates of depression: cross-national perspectives. J Affect Disord (1994) 2.25
Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl (1996) 2.14
Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med (2003) 2.07
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction (2003) 2.06
Procedural validity of standardized symptom questions for the assessment of psychotic symptoms--a comparison of the DIS with two clinical methods. Compr Psychiatry (1988) 1.99
An international study of psychological problems in primary care. Preliminary report from the World Health Organization Collaborative Project on 'Psychological Problems in General Health Care'. Arch Gen Psychiatry (1993) 1.86
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry (2001) 1.86
Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults. Arch Gen Psychiatry (2001) 1.85
The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am (2001) 1.72
Parental alcohol use disorders and alcohol use and disorders in offspring: a community study. Psychol Med (2002) 1.71
Gender differences in adolescents and young adults with suicidal behaviour. Acta Psychiatr Scand (2001) 1.71
Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry (2000) 1.68
Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol (1993) 1.67
Parental psychopathology, parenting styles, and the risk of social phobia in offspring: a prospective-longitudinal community study. Arch Gen Psychiatry (2000) 1.63
The cross-national epidemiology of panic disorder. Arch Gen Psychiatry (1997) 1.61
Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? Eur Psychiatry (2000) 1.58
The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update. Eur Addict Res (2000) 1.56
The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend (2001) 1.52
Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry (1998) 1.51
Lifetime co-morbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol Med (1999) 1.50
The CIDI-core substance abuse and dependence questions: cross-cultural and nosological issues. The WHO/ADAMHA Field Trial. Br J Psychiatry (1991) 1.48
One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety (2001) 1.46
WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry (1994) 1.46
Risk factors for new depressive episodes in primary health care: an international prospective 12-month follow-up study. Psychol Med (2002) 1.44
Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults. Psychol Med (2003) 1.44
Panic and panic disorder in the United States. Am J Psychiatry (1994) 1.37
[A scale for the objective evaluation of the state of subjective well-being as a method for longitudinal studies]. Arzneimittelforschung (1970) 1.31
Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study. Int J Obes Relat Metab Disord (2000) 1.29
Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr Scand Suppl (1998) 1.29
Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview. Arch Gen Psychiatry (1989) 1.24
High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) (2008) 1.22
The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry (1984) 1.19
Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Pharmacol Biochem Behav (1983) 1.15
Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews? J Psychiatr Res (1994) 1.13
DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: how specific are panic attacks? J Psychiatr Res (1999) 1.10
A comparison of two diagnostic methods. Clinical ICD diagnoses vs DSM-III and Research Diagnostic Criteria using the Diagnostic Interview Schedule (version 2). Arch Gen Psychiatry (1985) 1.10
Covariates of cannabis use progression in a representative population sample of adolescents: a prospective examination of vulnerability and risk factors. Addiction (1999) 1.09
Comorbidity patterns in adolescents and young adults with suicide attempts. Eur Arch Psychiatry Clin Neurosci (1998) 1.07
The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol (2005) 1.05
DSM-IV alcohol disorders in a general population sample of adolescents and young adults. Addiction (1998) 1.05
Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. J Psychopharmacol (2008) 1.04
Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force. Br J Psychiatry Suppl (1996) 1.03
[Prevalence, detection and prescribing behavior in depressive syndromes. A German federal family physician study]. Nervenarzt (2002) 1.03
Evaluation of depressive states, especially in longitudinal studies. Mod Probl Pharmacopsychiatry (1974) 1.03
Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) substance use sections. Eur Addict Res (1998) 1.00
Smoking and nicotine dependence. Results from a sample of 14- to 24-year-olds in Germany. Eur Addict Res (1998) 0.99
Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments. Acta Psychiatr Scand (2000) 0.99
Prevalence and 12-month outcome of threshold and subthreshold mental disorders in primary care. J Affect Disord (1999) 0.99
Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction (1999) 0.98
Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample. Eur Addict Res (1998) 0.98
Specific fears and phobias. Epidemiology and classification. Br J Psychiatry (1998) 0.98
The frequency of social dysfunction in a general population sample and in patients with mental disorders. A comparison using the Social Interview Schedule (SIS). Soc Psychiatry Psychiatr Epidemiol (1988) 0.95
["Generalized anxiety and depression in primary care" (GAD-P). Study design and methods]. Fortschr Med Orig (2001) 0.95
Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr (1970) (1980) 0.95
The US National Comorbidity Survey: overview and future directions. Epidemiol Psichiatr Soc (1997) 0.94
Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry (1999) 0.94
Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta Psychiatr Scand (2004) 0.92
Prevalence, 20-month incidence and outcome of unipolar depressive disorders in a community sample of adolescents. Psychol Med (1999) 0.92
Anxiety and depression: comorbidity, psychopathology, and social functioning. Compr Psychiatry (1989) 0.91
Test-retest reliability of a standardized psychiatric interview (DIS/CIDI). Eur Arch Psychiatry Neurol Sci (1987) 0.91
Suicidal ideation and suicide attempts: comorbidity with depression, anxiety disorders, and substance abuse disorder. Eur Arch Psychiatry Clin Neurosci (1994) 0.91
Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community. Acta Psychiatr Scand (2010) 0.90
[Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses]. Nervenarzt (1984) 0.89
The overlap between depression and anxiety on different levels of psychopathology. J Affect Disord (1989) 0.89
Kinematical analysis of emotionally induced facial expressions in patients with obsessive-compulsive disorder. Psychol Med (2003) 0.89
[Do primary care physicians know generalized anxiety disorders? Estimations of prevalence, attitudes and interventions]. Fortschr Med Orig (2001) 0.88
Personality in patients with affective disorders and their relatives. J Affect Disord (1998) 0.88
An empirical comparison of diagnoses and reliabilities in ICD-10 and DSM-III-R. Eur Arch Psychiatry Clin Neurosci (1993) 0.87
The World Health Organization's cross-cultural study on neuropsychiatric aspects of infection with the human immunodeficiency virus 1 (HIV-1). Preparation and pilot phase. Br J Psychiatry (1991) 0.87
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord (2000) 0.87
Patterns of use and their relationship to DSM-IV abuse and dependence of alcohol among adolescents and young adults. Eur Addict Res (1998) 0.86
[Depressive states in schizophrenic in-patients on admission and at discharge (author's transl)]. Nervenarzt (1981) 0.86
Is the use of ecstasy and hallucinogens increasing? Results from a community study. Eur Addict Res (1998) 0.86
Ofloxacin-induced psychosis. Br J Psychiatry (1987) 0.86
Mental illness in a representative sample of homeless men in Munich, Germany. Eur Arch Psychiatry Clin Neurosci (1996) 0.85
Clinical psychology and psychotherapy: a survey of the present state of professionalization in 23 countries. Am Psychol (1980) 0.85
The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord (1985) 0.85
Development of diagnostic checklists for use in routine clinical care. A guideline designed to assess DSM-III-R diagnoses. Arch Gen Psychiatry (1990) 0.85
Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur Arch Psychiatry Clin Neurosci (2009) 0.84
[When and how well does the family physician recognize generalized anxiety disorders and depressions?]. Fortschr Med Orig (2001) 0.84
Anxiety and depression in a community sample: the influence of comorbidity on social functioning. J Affect Disord (1990) 0.84
A European perspective on social anxiety disorder. Eur Psychiatry (2000) 0.84
Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biol Psychiatry (1982) 0.84
Is there some indication from behavioral effects of endorphins for their involvement in psychiatric disorders? Adv Biochem Psychopharmacol (1978) 0.83
Routine psychiatric examinations guided by ICD-10 diagnostic checklists (International Diagnostic Checklists). Eur Arch Psychiatry Clin Neurosci (1993) 0.83
Anxiety and depression: the impact of shared characteristics on diagnosis and treatment. Introduction. Acta Psychiatr Scand Suppl (2000) 0.81